Skip to content
  • Who We Are
    • CPA President & Vice President
    • CPA Council
    • CPA Team
    • Alliances
    • Member Associations
    • Partners
    • Trustees
    • Patrons
    • Fellows
  • Strategy
    • Our Impact
  • Join
  • Careers
  • Our Work
    • AMR
    • COVID-19
    • CPD
    • PharmAid
    • Tools and Resources
  • Latest
    • Events
    • News
    • Blog
    • Publications
    • Work with Us
  • Support Us
  • Contact
Menu
  • Who We Are
    • CPA President & Vice President
    • CPA Council
    • CPA Team
    • Alliances
    • Member Associations
    • Partners
    • Trustees
    • Patrons
    • Fellows
  • Strategy
    • Our Impact
  • Join
  • Careers
  • Our Work
    • AMR
    • COVID-19
    • CPD
    • PharmAid
    • Tools and Resources
  • Latest
    • Events
    • News
    • Blog
    • Publications
    • Work with Us
  • Support Us
  • Contact
linkedinCreated with Sketch. InstagramCreated with Sketch. FacebookCreated with Sketch. TwitterCreated with Sketch. Youtube

Blog: CPA advocacy at the Commonwealth People’s Forum 2022

CPA advocacy at the Commonwealth People’s Forum (CHOGM 2022)

The theme for CHOGM 2022 was ‘Delivering a Common Future: Connecting, Innovating, Transforming.’ 

In the second of a series of 2 blogs, Ms Winnie Nambatya reports on the CPA’s attendance at the Commonwealth People’s Forum.

Emerging from the Pandemic: Antimicrobial Resistance — a Call to Action
The CPA led this side event, as an interactive discussion, highlighting the global picture of AMR and the urgency to act now.

We showcased key CPA initiatives, such as the Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programme, which aims to address AMR through innovation, partnerships and transformation. We also reflected on the opportunities and threats emerging from the COVID-19 pandemic regarding infection prevention and management, as well as discussed barriers to tackling AMR and key actions required to change health systems and behaviours in a sustainable manner.

During the discussion, delegates highlighted an urgent need to strengthen health systems and regulatory bodies in detecting falsified and counterfeit medications. There was also concern that some LMICs are using substandard and falsified medications which contribute to antimicrobial resistance (AMR). In some countries, regulatory bodies often lack the capacity to monitor health facilities and pharmacies; for example, in African countries, many pharmacies may dispense antimicrobials without a valid prescription; in the health facilities, antimicrobials are prescribed without microbiological evidence for their need. Furthermore, there was also strong concern about a lack of collaboration amongst health workers, especially between doctors and pharmacists.

The group agreed that there is an urgent call to action to educate health workers and communities on AMR.

Antimicrobial Resistance Global Leaders Group Event

The AMR Global Leaders Group, all experts from different backgrounds, led this session from a One Health approach, to drive collaboration and accelerate political action on AMR. They recognised that to mitigate AMR through responsible and sustainable access to and use of antibiotics, it is important to collaborate with governments, civil society organisations and the corporate sector on a global scale. The group also highlighted in this discussion that taking action to combat AMR is crucial not just for global health, but also for development, climate change, and future pandemic responses.

The Global Leaders concurred that to lessen the adverse outcome of untreatable infections, there was a driving need to increase funding for AMR surveillance, design, development and implementation of National Action Plans (NAP) that are costly and sustainable.

Malaria and Neglected Tropical Diseases (NTDs) Summit
Tremendous strides have been made toward treating  Malaria and Neglected Tropical Diseases (NTDs) since 2000 and yet they continue to take lives and put many at risk. This challenge was worsened by COVID-19. The Kigali Summit on Malaria and Neglected Tropical Diseases (NTDs) hosted by His Excellency Paul Kagame, President of the Republic of Rwanda brought together World leaders, who are committed to resolving the current challenges, including those posed by the  COVID-19 pandemic and ending these devastating diseases.

Eligible Malaria endemic countries demonstrated their leadership by committing domestic funding of $2.18 billion as part of their Global Funding. His Excellency, President Paul Kagame also launched the Kigali Declaration on NTDs.

 

Experts discussed integrated approaches to address NTDs, including the need for ongoing innovation; assurance on access to current and new tools, solutions and resources that are effective and data-driven. There was discussion on the mobilisation of resources, as well as the requirement for ongoing funding including from non-governmental organisations.

Some of the key commitments made:

 

  • A number of governments including Canada, Germany, Rwanda, UAE, the UK and the USA committed to support tackling AMR.
  • Private companies including BioNTech, Dentsu, Ecobank, GSK, Goodbye Malaria, Novartis, Medicines Development for Global Health and Pfizer, committed to a variety of activities such as donations of medicines and health products; funding research and enhancement of local manufacturing Trusts, Funds, Foundations, and Philanthropists: These groupings made substantial commitments towards research funding, new treatments for NTDs, prevention and delivery as well as strengthening institutions in Africa. Commitments were made by the Bill and Melinda Gates Foundation, the END Fund, The Global Fund to Fight TB, AIDS and Malaria, and the Wellcome Trust
  • Civil Society Organisations to assist the Malaria and NTD programming, including significant resource mobilization pledges and community involvement. AMREF, Impact Santé Afrique, and Sightsavers all pledged support.

‘Building Resilient and Equitable National Health Systems’ Session 

The session on “Building Resilient and Equitable National Health Systems” explored the need to strengthen health systems at local, regional and international levels as a key driver in securing UHC and the different ways to facilitate this, including through more effective coordination and collaboration between Commonwealth countries.

It was stated that recent years have served to highlight the numerous, interrelated factors that must come together to ensure strong national and global health systems, such as adequate attention to the social and economic determinants of health; governance structures must enable financial and human resources to be mobilised, deployed, and reconfigured in order to deliver services as and where needed; and the capacity to implement evidence-based practices. 

It is vital that support and aid delivery methods be improved on a global scale, especially in times of a health emergency. It was also noted that Civil Societies have an important role in UHC; they are closest to their local communities, able to advocate for marginalised members of their societies and have a much deeper understanding of local cultures.

Their knowledge enables them to effectively advocate for change and target financing from Governments.

The Commonwealth was urged to advocate for inclusivity for all – there is a need to advocate for UHC and include people with disabilities and of all genders, races, and religions,  The Commonwealth was further tasked and encouraged to advocate for the end of out-of-pocket expenditure.

 

Photo credits: CHOGM Rwanda 2022

Winnie Nambatya

Ms. Winnie Nambatya is a Lecturer of Clinical Pharmacy at Makerere University and a member of the antimicrobial access and use technical working committee at the ministry of health. Ms. She is currently the in-country consultant for the CommonWealth Pharmacists’ Association supporting the antimicrobial stewardship partnership program under which she has been crucial to the development and capacity-strengthening of health workers in Uganda.

Get the latest

Events
News
Blog
Events

CPA presents programme insights at the 9th PCNE Working Symposium

June 25, 2024

Dr. Gizem Gülpınar shared evaluation findings from CPA programmes at the 9th PCNE Symposium, focusing on AMS, AMR and SFMs.

2024 Commonwealth Pharmacists Day – Pharmacists developing resilient and sustainable health systems

June 11, 2024

2024 Commonwealth Pharmacists Day – Pharmacists Developing Resilient and Sustainable Health Systems for all About the Day Welcome to the official page for Commonwealth Pharmacists

2023 Commonwealth Pharmacists Day – Your Pharmacist, Your Partner in Health

June 13, 2023

2023 Commonwealth Pharmacists Day – Your Pharmacist, Your Partner in Health About the Day Welcome to the official page for Commonwealth Pharmacists Day, celebrated every

Celebrating our achievements at the Antibiotic Guardian Awards 2023

May 12, 2023

Celebrating our achievements at the Antibiotic Guardian Awards 2023 The sixth Antibiotic Guardian Shared Learning and Awards event took place on the 2nd of May 2023

News

Celebrating women today, and every day​

March 8, 2025

A special message from the President of the Commonwealth Pharmacists Association, Annagrace Malamsha, for International Womens’ Day on March 8th, 2025.

The impact of CwPAMS in Ghana

December 30, 2024

Sarah Cavanagh, our AMS Senior Technical Advisor, reflects on her recent visit to Ghana as part of our Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) programme.

One Resilient Future: Transforming our Commonwealth

November 15, 2024

Learn about CPA’s role advocating for improved healthcare at the 2024 Commonwealth Heads of Government Meeting in Samoa.

CPA at the 82nd FIP World Congress​

October 15, 2024

The annual gathering of the International Pharmaceutical Federation is a unique opportunity for the Commonwealth Pharmacists Association (CPA) to connect with members and global partners, disseminate learnings from our research and showcase the impact of our work on a global scale.

Blog

Empowering Pharmacists to Be the Difference in Ending Tuberculosis​

March 25, 2024

Empowering Pharmacists to Be the Difference in Ending Tuberculosis World Tuberculosis Day shines a spotlight on a disease that, despite being preventable and curable, continues

How Women of the CPA are Accelerating Healthcare Progress Across the Commonwealth

March 8, 2024

International Women’s Day 2024: Invest in women—accelerate progress Leading with Impact: How Women of the CPA are Accelerating Healthcare Progress Across the Commonwealth At the

Reflections on 2023

February 1, 2024

Reflections on 2023 As we step into 2024, the Commonwealth Pharmacists Association (CPA) looks back on an impactful year of advocacy, expanding our footprint on

World AMR Awareness Week 2023

November 20, 2023

World AMR Awareness Week 2023 Preventing antimicrobial resistance together Every year, World AMR Awareness Week (WAAW) takes place between the 18th to 24th of November. 

Who we are

  • Alliances
  • Membership
  • Contact Us
  • Our Constitution
  • Alliances
  • Membership
  • Contact Us
  • Our Constitution

About us

  • Strategy
  • News
  • Blog
  • Safeguarding Policy
  • Strategy
  • News
  • Blog
  • Safeguarding Policy

Our work

  • AMR
  • COVID-19
  • CPD
  • PharmAid
  • Tools and Resources
  • AMR
  • COVID-19
  • CPD
  • PharmAid
  • Tools and Resources
© 2026 CPA
  • Privacy Notice
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (EU)
  • Privacy Statement (EU)
  • Privacy Notice
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (EU)
  • Privacy Statement (EU)

CIO Registered charity number: 1176132

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}